Continuous peripheral nerve block catheters are applicable in performing a nerve block process to relieve pain. The continuous peripheral nerve block, also called as perineural local anesthetic infusion, is a method majorly executed in ambulatory medical centres and hospitals, where percutaneous insertion of the catheter, parallel to peripheral nerve is made for management of anesthesia via catheter.The continuous peripheral nerve block catheter market is anticipated to account for revenues worth US$ 700 Mn by the end of 2026 owing to rising adoption of CPNB catheter particularly in hospitals. Growing precision of catheter engagement and cost effective procedure compared to alternative procedures used for management of analgesia are key factors fuelling adoption of continuous peripheral nerve block catheters.
Rising occurrence of chronic disorders, such as osteoarthritis, is a key reason for increasing upper/lower extremity joint replacement processes. The CPNB is highly recommended for management of post joint replacement and analgesia methods for pain relief. Above factors are anticipated to boost revenue growth of global CPNB catheter market over the forecast period (2016-2026). Minimum hospital stay and cost efficiency offered by CPNB catheters are fueling revenue growth of global CPNB catheter market. Lack of trained professionals for replacement and standard usage strategies for the placement of CPNB catheters, and difficulties associated with devices are anticipated to reduce growth of global CPNB catheter market. Some major trends in CPNB catheter market consist of strategic marketing campaigns, product innovation & modifications, partnerships & acquisitions for rising consumer base.
The U.S. will Remain Most Lucrative CPNB Catheter Market : North America is anticipated to remain dominant in the global CPNB catheter market and is expected to register 6.4% CAGR in terms of value. The U.S. will remain lucrative market in North America over the forecast period. North America accounted for approximately half revenue share of global CPNB catheter market in 2015.CPNB catheter market in Japan is anticipated to grow at healthy CAGR throughout the forecast period. Asia Pacific Excluding Japan (APEJ) market had accounted for 10.2% revenue share of CPNB catheter market of the globe by 2016-end.
Product Type Segmentation : The non-stimulating catheter procedure segment is estimated to generate maximum revenue share of the CPNB catheter market. ‘Over the needle’ catheter procedure segment is anticipated to account for comparatively lowest CAGR in terms of value. Higher stimulating catheter system segment is anticipated to dominate the global CPNB catheter market in terms of volume.
Insertion Technique Type Segmentation : Ultrasound segment, in terms of value, is anticipated to register a higher CAGR, compared to nerve stimulation segment. Rising acceptance of ultrasound guided catheter procedure is anticipated to fuel revenue growth of global CPNB catheter market. Ultrasound segment generated 36.8% revenue share of global CPNB catheter market in 2015. A decrease in the revenue share of nerve stimulation technique is expected due to less precision offerings.
End-User Type Segmentation : Hospitals segment is anticipated to register higher CAGR, compared to ASCs segment by the forecast period. Rising adoption of CPNB catheter is the key factor that boosts revenue growth of the hospital segment, since joint replacement procedure is majorly performed in hospitals. The hospital segment is expected to generate 64.8% revenue share by the end of 2026.Some leading market player profiled in this report are Teleflex Incorporated, B. Braun Melsungen AG, Halyard Health, Inc., Pajunk GmbH and Ambu A/S, Epimed International Inc. Owing to wide product portfolio, B. Braun Melsungen AG was the leading market player in CPNB catheter market in 2015.
Request and Download Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1307